Brief: Lantern Pharma Confirms Panna Sharma Continues To Serve As President And CEO Alerts Investors To False Third-Party Report
27/03/2026 23:24
March 27 (Reuters) - Lantern Pharma Inc LTRN.O: LANTERN PHARMA CONFIRMS PANNA SHARMA CONTINUES TO SERVE AS PRESIDENT AND CEO; ALERTS INVESTORS TO FALSE THIRD-PARTY REPORT LANTERN PHARMA INC: INTENDS TO PURSUE ALL AVAILABLE LEGAL REMEDIES AND IS CONSIDERING REFERRING THIS MATTER TO THE APPROPRIATE REGULATORY AUTHORITIES Source text: ID:nBw7FR85Wa Further company coverage: LTRN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lantern Pharma
See all newsBrief: Lantern Pharma Receives Taiwan Approvals To Open Next Stage Of Phase 2 Harmonic Trial Of Lp-300 In Never-Smoker, Egfr-Mutant Nsclc
Brief: Lantern Pharma Reports Second Quarter 2026 Financial Results And Provides Business Update
Lantern Pharma Inc reports results for the quarter ended June 30 - Earnings Summary
Lantern Pharma Q2 operating loss widens on warrant expenses tied to higher stock price
Lantern Pharma Inc expected to post a loss of 38 cents a share - Earnings Preview